1887
Volume 2003, Issue 2
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

Objective. To review the role of intravenous immunoglobulin (IVIG) in the prevention of recurrent miscarriage (RM). Methods. In a prospective controlled clinical tria], 40 women with a history of unexplained. RMwere treated with IVIG, according to a specific protocol and compared to another 40 women who had the same condition and treated with tender loving care and vitamins only. The birth of a child of more than 28 weeks gestation was considered a successful outcome.

Results. The overall success rate was 60% in the IVIG group compared with 52.6% in the control group (P = 0.65). The success rates for women with primary RM were 56.3% for IVIG group and 68.8% for the control group (P = 0.72). The success rates for women with secondary RM were 62.5% and 41.7% respectively (P = 0.25). None of the previous results is statistically significant.

Conclusion. Women with unexplained RM in general have a good prognosis. IVIG did not improve the prognosis significantly in the total group of patients compared with controls. However; further investigations are needed to explore whether the 21 % therapeutic benefit of IVIG in patients with secondary RM indicates that the treatment is efficient in this subset of patients.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2003.2.9
2003-12-01
2019-08-18
Loading full text...

Full text loading...

References

  1. 1. Carp   HJA., , Toder   V., , Gazit   E., , Ahiron   A., , Torchinski   S., , Mashiash   S., , Shoenfeld   Y. . Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis. . American Journal of Reproductive Immunology . 2001; ;46: : 268– 273 .
    [Google Scholar]
  2. 2. Christiansen   OB., , Mathiesen   0., , Lauritsen   JG., , Grunnet   N. . Intravenous immunoglobulin treatment of women with multiple miscarriages. . Human Reproduction . 1992; ;7: : 718– 722 .
    [Google Scholar]
  3. 3. Christiansen   OB., , Mathiesen   0., , Husth   M., , Rasmussen   KL., , Ingerslev   HJ., , Lauritsen   JG., , Grunnet   N. . Placebocontrolled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. . Human Reproduction . 1995; ;10: : 2690– 2695 .
    [Google Scholar]
  4. 4. Christiansen   OB., , Klipatrick   DC., , Souter   V., , Warming   K., , Thiel   S., , Jensenius   JC. . Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. . Scandinavian Journal of Immunology . 1998; ;49: : 193– 196 .
    [Google Scholar]
  5. 5. Christiansen   OB., , Pedersen   B., , Rosgaard   A., , Husth   M. . A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. . Human Reproduction . 2002; ;17: : 809– 816 .
    [Google Scholar]
  6. 6. Clifford   K., , Rai   R., , Watson   H., , Regan   L. . An informative protocol for the investigation of recurrent miscarriage: Preliminary experience of500 consecutive cases. . Human Reproduction . 1994; ;9: : 1328– 1332 .
    [Google Scholar]
  7. 7. Coulam   CB., , Krysa   L., , Stem   JJ., , Bustillo   M. . Intravenous immunoglobulin for treatment of recurrent pregnancy loss. . American Journal of Reproductive Immunology . 1995; ;34: : 333– 337 .
    [Google Scholar]
  8. 8. Daya   S., , Gunby   J., , Clark   DA. . Intravenous immunoglobulin therapy for recurrent spontaneous abortion: A metaanalysis. . American Journal of Reproductive Immunology . 1998; ;39: 2 : 69– 76 .
    [Google Scholar]
  9. 9. German RSA/IVIG group . Intravenous immunoglobulin in the prevention of recurrent miscarriage. . British Journal of Obstetrics and Gynaecology . 1994; ;101: : 1072– 1077 .
    [Google Scholar]
  10. 10. Heine   O., , Mueller-Eckhardt   G. . Intravenous immunoglobulin in recurrent abortion. . Clinical and Experimental Immunology . 1994; ;97: : 39– 42 .
    [Google Scholar]
  11. 11. Jablonowska   B., , Selbing   A., , Palfi   M., , Emerudh   J., , Kjellberg   S., , Lindton   B. . Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: A double-blind placebocontrolled study. . Human Reproduction . 1999; ;14: : 838– 841 .
    [Google Scholar]
  12. 12. Mueller-Eckhardt   G., , Heine   O., , Neppert   J., , Kunzel   W., , Mueller-Eckhardt   C. . Prevention of recurrent spontaneous abortion by intravenous immunoglobulin. . Vox Sang.   1989; ;56: : 151– 154 .
    [Google Scholar]
  13. 13. Mueller-Eckhardt   G., , Heine   O., , Polten   BIVIG. . to prevent recurrent spontaneous abortion. . Lancet . 1991; ;337: : 425– 426 .
    [Google Scholar]
  14. 14. Perino   A., , Vassiliadis   A., , Vucetich   A., , Colacurci   N., , Menato   G., , Cignitti   M., , Semprini   AE. . Short-term therapy for recurrent abortion using intravenous immunoglobulins: Results of a double-blind placebo-controlled Italian study. . Human Reproduction . 1997; ;12: : 2388– 2392 .
    [Google Scholar]
  15. 15. Pfeiffer   KA., , Fimmers   R., , Engels   G., , van der Yen   H., , Van der Yen   K. . The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. . Mol. Hum. Reprod.   2001; ;7: : 373– 378 .
    [Google Scholar]
  16. 16. Piccinni   MP., , Beloni   L., , Livi   C., , Maggi   E., , Scarselli   G., , Romagnani   S. . Defective production on both leukemia inhibitory factor and type-2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. . Nat Med . 1998; ; : 1020– 1024 .
    [Google Scholar]
  17. 17. Ronda   N., , Hurez   V., , Kazatchkine   MD. . Intravenous immunoglobulin therapy for autoimmune and systemic inflammatory diseases. . Vox Sang . 1993; ;64: : 65– 72 .
    [Google Scholar]
  18. 18. Sacks   G., , Sargent   I., , Redman   C. . An innate view of human pregnancy. . Immunology Today . 1999; ;20: : 114– 118 .
    [Google Scholar]
  19. 19. Stephenson   MD., , Dreher   K., , Houlihan   E., , Wu   V. . Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: A prospective, randomized, double-blinded, placebo-controlled trial. . American Journal of Reproductive Immunology . 1998; ;39: : 82– 88 .
    [Google Scholar]
  20. 20. Thornton   CA., , Ballow   M. . Safety of intravenous immunoglobulin. . Achieve of Neurology . 1993; ;50: : 135– 136 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2003.2.9
Loading
  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error